Ketamine Hydrochloride

• The additive effect of ketamine in combination with electroconvulsive stimulation (ECS) in major depressive disorder (MDD): a translational … Not authorised
  2024-512559-20-00 Phase III 1 country Universita' Vita-salute S. Raffaele
• Ketamine infusion for symptomatological improvement of severe borderline personality disorder: a pilot study Pending
  2024-514361-19-00 Phase II 1 country Centre Hospitalier Universitaire De Toulouse
• Evaluation of the effect of Opioid-Free Anesthesia on oxygenation in bariatric surgery Pending
  2024-519722-20-00 Phase II/III 1 country Fundacion Publica Andaluza Para La Investigacion De Malaga En Biomedicina Y Salu…
• Ketamine maintenance treatment for depression: A multicenter open-label randomized controlled trial (PreKET) Pending
  2025-521330-29-00 Phase II 1 country Ostfold Hospital Trust
• KARMA - INtenSive care TreAtmeNT with adjuvant KetAmine and Recovery after Mechanical ventilAtion: a multicenter doubleblind randomized cont… Pending
  2025-523149-80-00 Phase II/III 1 country Assistance Publique Hopitaux De Paris
• An Open-label Trial of Add-on Oral Slow-release Ketamine Treatment in Major Depression Recruiting
  2025-524841-28-00 Phase II 1 country Region Skane
• The additive effect of ketamine in combination with electroconvulsive stimulation (ECS) in major depressive disorder (MDD): a translational … Recruiting
  2024-512559-20-01 Phase III 1 country Universita' Vita-salute S. Raffaele
• Prospective comparative randomized study of procedural sedation during TAVR (Transcatheter Aortic Valve Replacement) Recruiting
  2024-511018-18-00 Phase III 1 country Azienda Socio Sanitaria Territoriale Ovest Milanese
• Pharmacologic treatment augmentation in chronic depression “randomized, controlled, double blinded, phase II study” Recruiting
  2024-512478-86-00 Phase II 1 country Universitaetsklinikum Tuebingen AöR
• Psilocybin - a strategy of rapid antidepressant response in depression comorbid with cancer,a randomized double-blind study with the possib… Recruiting
  2024-517747-31-00 Phase II 1 country Narodni Ustav Dusevniho Zdravi
• Investigation of neurobiological mechanisms of antidepressant action of ketamine using neuroimaging Recruiting
  2024-519234-23-00 Phase I (Other) 1 country Medical University Of Vienna
• Opioid-Free Analgesia In Intensive Care Unit (OFICU) Ended
  2024-517770-14-00 Phase IV 1 country Centre Hospitalier Universitaire De Nimes
• Antidepressant effects of psilocybin in pharmaco-resistant depression Ended
  2024-515899-13-00 Phase II 1 country Narodni Ustav Dusevniho Zdravi
• Ketamine Low dOse Evaluation on morphine consumption in traumatic patient Ended
  2023-510016-39-00 Phase III 1 country Assistance Publique Hopitaux De Marseille
• Respiratory effect of the LISA (Less Invasive surfactant administration) method with sedation by propofol versus absence of sedation: Double… Ended
  2024-518836-36-00 Phase III 1 country Centre Hospitalier Universitaire Grenoble Alpes
• Opioid-Free General Anesthesia Compared to Opioid-Based General Anesthesia for the Reduction of Postoperative Nausea and Vomiting in Patient… Halted
  2025-521047-20-00 Phase IV 1 country Institut De Recerca Biomedica De Lleida Fundacio Dr. Pifarre
• ESKAPE randomized controlled double-blind study: ESKetamine low-dose versus ketamine low-dose for Severe Acute Pain in the Emergency Departm… Ended
  2024-518733-29-00 Phase IV 1 country Centre Hospitalier Universitaire De Nice
• A randomized, double-blind, single-center, 2-period cross-over Phase I study to assess the tolerability, safety and pharmacokinetics of anti… Ended
  2023-503971-45-00 Phase I (Other) 1 country Ketabon GmbH
• Re-purposing of 2 well-known molecules (ketamine and magnesium sulfate) to treat a specific and excruciating type of pain (chronic cluster h… Ended
  2024-518943-38-00 Phase III 1 country University Hospital Of Clermont-Ferrand

Showing 1–19 of 19 trials